Beit Jala Pharmaceutical Company (PEX:BJP)
Palestine · Delayed Price · Currency is JOD 3.620
+0.020 (0.56%)
At close: Jan 13, 2026
PEX:BJP Ratios and Metrics
Market cap in millions JOD. Fiscal year is January - December.
Millions JOD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 25 | 25 | 20 | 20 | 20 | 19 | |
Market Cap Growth | 29.29% | 28.57% | 0% | -1.75% | 5.56% | 5.88% |
Enterprise Value | 24 | 23 | 20 | 19 | 21 | 21 |
Last Close Price | 3.47 | 3.45 | 2.57 | 2.48 | 2.43 | 2.30 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 11.39 | 9.22 | 11.16 | 10.67 | 10.07 | 21.70 |
PS Ratio | 2.05 | 1.97 | 2.03 | 2.04 | 1.85 | 1.94 |
PB Ratio | 1.24 | 1.28 | 1.27 | 1.34 | 1.51 | 1.52 |
P/TBV Ratio | 1.24 | 1.28 | 1.27 | 1.34 | 1.51 | 1.52 |
P/FCF Ratio | - | 173.03 | 89.61 | 29.24 | 7.09 | 70.56 |
P/OCF Ratio | 7.66 | 5.64 | 21.66 | 10.13 | 6.20 | 17.36 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.91 | 1.83 | 2.10 | 2.00 | 1.91 | 2.16 |
EV/EBITDA Ratio | 3.95 | 3.72 | 7.78 | 5.89 | 6.22 | 9.94 |
EV/EBIT Ratio | 8.38 | 7.05 | 10.53 | 8.90 | 8.73 | 19.01 |
EV/FCF Ratio | - | 160.68 | 92.58 | 28.65 | 7.30 | 78.56 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.04 | 0.03 | 0.09 | 0.06 | 0.14 | 0.27 |
Debt / EBITDA Ratio | 0.14 | 0.10 | 0.56 | 0.29 | 0.55 | 1.57 |
Debt / FCF Ratio | - | 4.24 | 6.64 | 1.39 | 0.65 | 12.41 |
Net Debt / Equity Ratio | -0.05 | -0.04 | 0.06 | 0.02 | 0.06 | 0.20 |
Net Debt / EBITDA Ratio | -0.17 | -0.12 | 0.35 | 0.07 | 0.23 | 1.17 |
Net Debt / FCF Ratio | 0.95 | -5.35 | 4.12 | 0.35 | 0.26 | 9.23 |
Asset Turnover | 0.55 | 0.58 | 0.51 | 0.52 | 0.56 | 0.53 |
Inventory Turnover | 2.13 | 2.07 | 1.94 | 2.02 | 2.26 | 2.64 |
Quick Ratio | 3.51 | 3.59 | 2.07 | 2.49 | 1.60 | 1.18 |
Current Ratio | 5.15 | 5.56 | 3.52 | 4.45 | 2.44 | 1.94 |
Return on Equity (ROE) | 12.14% | 15.57% | 11.70% | 13.23% | 15.45% | 7.13% |
Return on Assets (ROA) | 7.76% | 9.49% | 6.30% | 7.22% | 7.60% | 3.77% |
Return on Invested Capital (ROIC) | 13.30% | 17.18% | 11.59% | 14.06% | 13.67% | 6.32% |
Return on Capital Employed (ROCE) | 12.60% | 15.50% | 11.40% | 13.30% | 15.70% | 7.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 8.79% | 10.85% | 8.96% | 9.37% | 9.93% | 4.61% |
FCF Yield | -4.32% | 0.58% | 1.12% | 3.42% | 14.11% | 1.42% |
Dividend Yield | 3.31% | - | 4.67% | 4.04% | 4.11% | 4.34% |
Payout Ratio | 37.73% | 30.72% | 39.86% | 38.10% | 35.33% | 80.36% |
Total Shareholder Return | 3.22% | - | 4.67% | 4.04% | 4.11% | 4.34% |